Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$UURAF Ucore Rare Metals Inc. is a junior exploration and technology company. The Company is engaged in the exploration and development of rare earth element properties within Canada and the United States. The Company is focusing its exploration activities on its Bokan Mountain/Dotson Ridge property in Alaska. The Bokan Mountain project is located on Prince of Wales Island, Alaska, approximately 60 kilometers southwest of Ketchikan, Alaska and over 140 kilometers northwest of Prince Rupert, British Columbia. Its projects also include Seagull Tin property, which is located in the Southwestern Yukon, and Sandybeach Lake property, which is located in southwestern Nunavut. The Company focuses to acquire the exclusive rights to Superlig Molecular Recognition separation technology (MRT) process for rare earth separation among other applications. This technology is used by the Company to separate the entire suite of rare earth elements from Bokan ore.
Company Contact
Headquarters
210 Waterfront Dr
Bedford B4A 0H3
CAN
http://ucore.com/
$UURAF Ucore Rare Metals Inc. is a junior exploration and technology company. The Company is engaged in the exploration and development of rare earth element properties within Canada and the United States. The Company is focusing its exploration activities on its Bokan Mountain/Dotson Ridge property in Alaska. The Bokan Mountain project is located on Prince of Wales Island, Alaska, approximately 60 kilometers southwest of Ketchikan, Alaska and over 140 kilometers northwest of Prince Rupert, British Columbia. Its projects also include Seagull Tin property, which is located in the Southwestern Yukon, and Sandybeach Lake property, which is located in southwestern Nunavut. The Company focuses to acquire the exclusive rights to Superlig Molecular Recognition separation technology (MRT) process for rare earth separation among other applications. This technology is used by the Company to separate the entire suite of rare earth elements from Bokan ore.
Company Contact
Headquarters
210 Waterfront Dr
Bedford B4A 0H3
CAN
http://ucore.com/
****** $TYME Phase II TYME-88-Panc Study Evaluating SM-88 Continues to Demonstrate Encouraging Results and Well-Tolerated Safety Profile >TYME
****** $TYME Phase II TYME-88-Panc Study Evaluating SM-88 Continues to Demonstrate Encouraging Results and Well-Tolerated Safety Profile >TYME
**** $NIO 3.465 +0.085 (+2.51%)
**** $NIO 3.465 +0.085 (+2.51%)
$TYME Tyme $TYME Tyme $TYME Tyme $TYME Tyme $TYME Tyme $TYME Tyme $TYME Tyme $TYME Tyme $TYME Tyme
$TYME Tyme $TYME Tyme $TYME Tyme $TYME Tyme $TYME Tyme $TYME Tyme $TYME Tyme $TYME Tyme $TYME Tyme
$TYME Tyme Technologies, Inc. is a clinical-stage biotechnology company. The Company is focused on developing cancer therapeutics that is intended to be broadly effective across tumor types and have low toxicity profiles. The Company's therapeutic approach is designed to take advantage of a cancer cell's innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body's natural immune system. The Company's lead clinical program, SM-88, is a first-in-class combination therapy in Phase II development for prostate cancer, and it is preparing to initiate an additional Phase II clinical trial for pancreatic cancer. The Company provides a novel compound for physicians to use in a treatment regimen for patients fighting six major cancers including breast, lung, prostate, gastric, esophageal and pancreatic cancers.
Company Contact
Headquarters
17 State St Fl 7
New York, NY 10004-1585
https://www.tymeinc.com/
$TYME - Pancreatic Cancer Info
$TYME Tyme Technologies, Inc. is a clinical-stage biotechnology company. The Company is focused on developing cancer therapeutics that is intended to be broadly effective across tumor types and have low toxicity profiles. The Company's therapeutic approach is designed to take advantage of a cancer cell's innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body's natural immune system. The Company's lead clinical program, SM-88, is a first-in-class combination therapy in Phase II development for prostate cancer, and it is preparing to initiate an additional Phase II clinical trial for pancreatic cancer. The Company provides a novel compound for physicians to use in a treatment regimen for patients fighting six major cancers including breast, lung, prostate, gastric, esophageal and pancreatic cancers.
Company Contact
Headquarters
17 State St Fl 7
New York, NY 10004-1585
https://www.tymeinc.com/
Good news in the fight against pancreatic cancer | Laura Indolfi | TEDxBoulder
$TYME Explodes!
Good news in the fight against pancreatic cancer | Laura Indolfi | TEDxBoulder
**** $TYME 1.21 +0.090 (+8.04%) ******
**** $TYME 1.21 +0.090 (+8.04%) ******
$TYME The 2 analysts offering 12-month price forecasts for Tyme Technologies Inc have a median target of 9.25, with a high estimate of 9.50 and a low estimate of 9.00. The median estimate represents a +690.60% increase from the last price of 1.17. https://money.cnn.com/quote/forecast/forecast.html?symb=tyme
$TYME The 2 analysts offering 12-month price forecasts for Tyme Technologies Inc have a median target of 9.25, with a high estimate of 9.50 and a low estimate of 9.00. The median estimate represents a +690.60% increase from the last price of 1.17.
$NIO Named The Fast Company’s Annual List Of The World’s Most Innovative Companies for 2019 https://www.businesswire.com/news/home/20190220005309/en/NIO-Named-Fast-Company%E2%80%99s-Annual-List-World%E2%80%99s
$NIO Named The Fast Company’s Annual List Of The World’s Most Innovative Companies for 2019 https://www.businesswire.com/news/home/20190220005309/en/NIO-Named-Fast-Company%E2%80%99s-Annual-List-World%E2%80%99s
Cancer Biotech $TYME is on FIRE!!!!!!!!!!!!
Cancer Biotech $TYME is on FIRE!!!!!!!!!!!!
$NIO Great NIO article today (Best new electric car):
https://www.yicaiglobal.com/news/nev-start-up-nio-outstrips-competitors-to-rank-best-in-green-auto-quality-study-finds
$NIO Great NIO article today (Best new electric car):
https://www.yicaiglobal.com/news/nev-start-up-nio-outstrips-competitors-to-rank-best-in-green-auto-quality-study-finds
The 11 analysts offering 12-month price forecasts for Nio Inc $NIO have a median target of 24.73, with a high estimate of 86.75 and a low estimate of 11.70. The median estimate represents a +617.73% increase from the last price of 3.45. https://money.cnn.com/quote/forecast/forecast.html?symb=NIO
$NIO The 11 analysts offering 12-month price forecasts for Nio Inc have a median target of 24.73, with a high estimate of 86.75 and a low estimate of 11.70. The median estimate represents a +617.73% increase from the last price of 3.45. https://money.cnn.com/quote/forecast/forecast.html?symb=NIO
$TYME "We are increasingly encouraged that SM-88 has the potential to be a new treatment approach for late-stage pancreatic patients." (link: https://www.marketwatch.com/story/tyme-technologies-stock-soars-on-heavy-volume-after-upbeat-update-to-cancer-treatment-study-2019-07-05) marketwatch.com/story/tyme-tec…
$TYME "We are increasingly encouraged that SM-88 has the potential to be a new treatment approach for late-stage pancreatic patients." (link: https://www.marketwatch.com/story/tyme-technologies-stock-soars-on-heavy-volume-after-upbeat-update-to-cancer-treatment-study-2019-07-05) marketwatch.com/story/tyme-tec…
$CHK Top Buys by Top Brass: CEO Lawler's $101K Bet on $CHK
(link: https://www.nasdaq.com/article/top-buys-by-top-brass-ceo-lawlers-101k-bet-on-chk-cm1181649) nasdaq.com/article/top-bu…
$CHK Top Buys by Top Brass: CEO Lawler's $101K Bet on $CHK
(link: https://www.nasdaq.com/article/top-buys-by-top-brass-ceo-lawlers-101k-bet-on-chk-cm1181649) nasdaq.com/article/top-bu…
$chk CHK $CHK $chk CHK $CHK $chk CHK $CHK $chk CHK $CHK $chk CHK $CHK $chk CHK $CHK $chk CHK $CHK
$chk CHK $CHK $chk CHK $CHK $chk CHK $CHK $chk CHK $CHK $chk CHK $CHK $chk CHK $CHK $chk CHK $CHK
$NIO Nio Plant Venture Landed huge $1.5 Billion Investment. China’s Nio Inc will form a joint venture with Beijing E-Town International Investment and Development Co. Ltd which will invest 10 billion yuan ($1.45 billion) in the new entity, the EV maker. E-Town Capital will support a new manufacturing facility for Nio’s next-generation platform 2.0 (NP2) vehicles, it said, adding the parties are continuing to work towards a final binding definitive agreement on the investment. https://www.advancedmobilityproject.com/blog/post/nio-lands-15-billion-investment-
$NIO Nio Plant Venture Landed huge $1.5 Billion Investment. China’s Nio Inc will form a joint venture with Beijing E-Town International Investment and Development Co. Ltd which will invest 10 billion yuan ($1.45 billion) in the new entity, the EV maker. E-Town Capital will support a new manufacturing facility for Nio’s next-generation platform 2.0 (NP2) vehicles, it said, adding the parties are continuing to work towards a final binding definitive agreement on the investment. https://www.advancedmobilityproject.com/blog/post/nio-lands-15-billion-investment-
$NIO Nio Plant Venture Landed huge $1.5 Billion Investment. China’s Nio Inc will form a joint venture with Beijing E-Town International Investment and Development Co. Ltd which will invest 10 billion yuan ($1.45 billion) in the new entity, the EV maker. E-Town Capital will support a new manufacturing facility for Nio’s next-generation platform 2.0 (NP2) vehicles, it said, adding the parties are continuing to work towards a final binding definitive agreement on the investment. https://www.advancedmobilityproject.com/blog/post/nio-lands-15-billion-investment-
Nio $NIO takes on Tesla $TSLA with a car half the price of Model X
https://investorplace.com/2019/02/if-you-liked-tesla-then-you-have-to-love-nio-now-fimg/
Nio $NIO takes on Tesla $TSLA with a car half the price of Model X
https://investorplace.com/2019/02/if-you-liked-tesla-then-you-have-to-love-nio-now-fimg/
$nio Nio Stock Increasingly Looks Like It’s Worth Revisiting
https://investorplace.com/2019/06/nio-stock-worth-revisiting/
$nio Nio Stock Increasingly Looks Like It’s Worth Revisiting
https://investorplace.com/2019/06/nio-stock-worth-revisiting/
$NIO Democrats Back Bill to Ban Sale of Gas-Powered Cars by 2040
https://www.dailysignal.com/2019/05/15/democrats-back-bill-to-ban-sale-of-gas-powered-cars-by-2040/